rs375754042
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001164279.2(SLC37A4):c.-15G>T variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000667 in 1,605,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001164279.2 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC37A4 | NM_001164279.2 | c.-15G>T | 5_prime_UTR_premature_start_codon_gain_variant | Exon 4 of 11 | NP_001157751.1 | |||
SLC37A4 | NM_001164278.2 | c.205G>T | p.Val69Leu | missense_variant | Exon 4 of 12 | NP_001157750.1 | ||
SLC37A4 | NM_001164277.2 | c.205G>T | p.Val69Leu | missense_variant | Exon 4 of 11 | NP_001157749.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000773 AC: 18AN: 232972Hom.: 0 AF XY: 0.0000555 AC XY: 7AN XY: 126128
GnomAD4 exome AF: 0.0000337 AC: 49AN: 1452930Hom.: 0 Cov.: 32 AF XY: 0.0000305 AC XY: 22AN XY: 721836
GnomAD4 genome AF: 0.000381 AC: 58AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000403 AC XY: 30AN XY: 74454
ClinVar
Submissions by phenotype
Glucose-6-phosphate transport defect Uncertain:3
- -
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 69 of the SLC37A4 protein (p.Val69Leu). This variant is present in population databases (rs375754042, gnomAD 0.1%). This variant has not been reported in the literature in individuals affected with SLC37A4-related conditions. ClinVar contains an entry for this variant (Variation ID: 529222). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SLC37A4 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided Uncertain:2
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
- -
Inborn genetic diseases Uncertain:1
The p.V69L variant (also known as c.205G>T), located in coding exon 2 of the SLC37A4 gene, results from a G to T substitution at nucleotide position 205. The valine at codon 69 is replaced by leucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Glucose-6-phosphate transport defect;C0342749:Phosphate transport defect;C5561986:Congenital disorder of glycosylation, type IIw Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at